ReviewJournal of preventive medicine and hygiene2024

First real-world data on universal respiratory syncytial virus prophylaxis with Nirsevimab in infants.

Andrea Orsi et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.